Noor E Nader, Alexandra R Glathar, Elaine V Byrnes, Marion Joy, Tengziyi Ge, Andrew Elliott, Ryan Jaehne, Caroline J Layding, Curtis Mamoru Tatsuoka, Gabriel Sica, Rajesh Acharya, Riyue Bao, Anthony R Cillo, Aron Y Joon, Swaminathan Kumar, Rami B Yanes, Xiancheng Wu, Luisa M Solis Soto, Claudio A Arrechedera, Auriole Tamegnon, Beatriz Sanchez-Espiridion, Hussein A Tawbi, Elizabeth M Burton, Michael A Davies, Thomas M Pearce, Timothy F Burns, Laura P Stabile, Xiaoran Zhang, Tullia C Bruno
{"title":"Functionally active lymphoid aggregates correlate with improved prognosis in brain metastases.","authors":"Noor E Nader, Alexandra R Glathar, Elaine V Byrnes, Marion Joy, Tengziyi Ge, Andrew Elliott, Ryan Jaehne, Caroline J Layding, Curtis Mamoru Tatsuoka, Gabriel Sica, Rajesh Acharya, Riyue Bao, Anthony R Cillo, Aron Y Joon, Swaminathan Kumar, Rami B Yanes, Xiancheng Wu, Luisa M Solis Soto, Claudio A Arrechedera, Auriole Tamegnon, Beatriz Sanchez-Espiridion, Hussein A Tawbi, Elizabeth M Burton, Michael A Davies, Thomas M Pearce, Timothy F Burns, Laura P Stabile, Xiaoran Zhang, Tullia C Bruno","doi":"10.1158/2159-8290.CD-25-0731","DOIUrl":null,"url":null,"abstract":"<p><p>B cells and their cellular neighborhoods, i.e., lymphoid aggregates (LAs) and tertiary lymphoid structures (TLS), have not been extensively studied in melanoma brain metastases (BM) or lung adenocarcinoma (LUAD) BM, despite their prognostic value and role in immunotherapeutic responses. In this study, we evaluated the prognostic benefit and heterogeneity of B cell infiltration and LA formation in more than 200 patients with melanoma-BM or LUAD-BM. We found that LAs were associated with increased intratumoral CD8+T cells in melanoma-BM compared with LUAD-BM. Moreover, the presence of LAs was associated with an increased survival benefit in patients with melanoma-BM but not in those with LUAD-BM. Despite lacking canonical TLS hallmarks, LAs in BM contained proliferating B and T cells with the potential for effector function. Our work has solidified the need for the mechanistic investigation of intracranial B cells and the immune neighborhoods in which they reside.</p>","PeriodicalId":9430,"journal":{"name":"Cancer discovery","volume":" ","pages":""},"PeriodicalIF":29.5000,"publicationDate":"2026-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer discovery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1158/2159-8290.CD-25-0731","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
B cells and their cellular neighborhoods, i.e., lymphoid aggregates (LAs) and tertiary lymphoid structures (TLS), have not been extensively studied in melanoma brain metastases (BM) or lung adenocarcinoma (LUAD) BM, despite their prognostic value and role in immunotherapeutic responses. In this study, we evaluated the prognostic benefit and heterogeneity of B cell infiltration and LA formation in more than 200 patients with melanoma-BM or LUAD-BM. We found that LAs were associated with increased intratumoral CD8+T cells in melanoma-BM compared with LUAD-BM. Moreover, the presence of LAs was associated with an increased survival benefit in patients with melanoma-BM but not in those with LUAD-BM. Despite lacking canonical TLS hallmarks, LAs in BM contained proliferating B and T cells with the potential for effector function. Our work has solidified the need for the mechanistic investigation of intracranial B cells and the immune neighborhoods in which they reside.
期刊介绍:
Cancer Discovery publishes high-impact, peer-reviewed articles detailing significant advances in both research and clinical trials. Serving as a premier cancer information resource, the journal also features Review Articles, Perspectives, Commentaries, News stories, and Research Watch summaries to keep readers abreast of the latest findings in the field. Covering a wide range of topics, from laboratory research to clinical trials and epidemiologic studies, Cancer Discovery spans the entire spectrum of cancer research and medicine.